Início › Leucemia Linfocítica Crônica › Carolina do Norte › Durham
Ensaios clínicos de Leucemia Linfocítica Crônica em Durham, NC
27 estudos para Leucemia Linfocítica Crônica estão buscando participantes em locais em Durham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecrutandoFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecrutandoFase 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
- University of North Carolina-Hillsborough Campus, Hillsborough · a 13 mi de distância
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RecrutandoFase 3
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi de distância
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
RecrutandoFase 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecrutandoFase 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi de distância
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecrutandoFase 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecrutandoFase 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
RecrutandoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi de distância
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RecrutandoFase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · a 10 mi de distância
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecrutandoFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · a 10 mi de distância
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
RecrutandoFase 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecrutandoFase 1
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Recrutando
- North Carolina Basnight Cancer Hospital, Chapel Hill · a 10 mi de distância
Registry of Older Patients With Cancer
RecrutandoEstudo observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi de distância
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecrutandoFase 1
- University of North Carolina, Chapel Hill · a 10 mi de distância
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
RecrutandoFase 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
RecrutandoFase 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
RecrutandoFase 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
RecrutandoFase 2
- University of North Carolina /ID# 233313, Chapel Hill · a 10 mi de distância
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
RecrutandoFase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RecrutandoFase 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecrutandoEstudo observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi de distância
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecrutandoFase 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecrutandoFase 1
- University of North Carolina, Chapel Hill · a 10 mi de distância
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
RecrutandoFase 1
- Duke University, Durham
Ensaios de Leucemia Linfocítica Crônica em outras cidades
- Boston, MA31 estudos
- Columbus, OH28 estudos
- Washington, DC22 estudos
- Seattle, WA20 estudos
- Rochester, MN19 estudos
- New York City, NY18 estudos
- Houston, TX17 estudos
- Baldwin Park, CA16 estudos
- Milwaukee, WI15 estudos
- Chicago, IL14 estudos
- Cincinnati, OH14 estudos
- Nashville, TN13 estudos
Outros estudos em Durham
- Câncer de Mama63 estudos
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células39 estudos
- Mieloma Múltiplo37 estudos
- Câncer Metastático33 estudos
- Leucemia Mieloide Aguda33 estudos
- Câncer de Pulmão32 estudos
- Câncer de Próstata32 estudos
- Câncer Colorretal28 estudos
- Câncer de Ovário27 estudos
- Insuficiência Cardíaca26 estudos
- Câncer de Pâncreas24 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.